A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

被引:12
|
作者
Eoh, Kyung Jin [1 ]
Yoon, Jung Won [1 ]
Lee, Jung-Yun [1 ]
Nam, Eun Ji [1 ]
Kim, Sunghoon [1 ]
Kim, Sang Wun [1 ]
Kim, Young Tae [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Inst Womens Med Life Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
来源
BMC CANCER | 2017年 / 17卷
基金
新加坡国家研究基金会;
关键词
Epithelial ovarian cancer; Laparoscopy; Cytoreduction surgical procedures; Debulking surgical procedures; SUBOPTIMAL PRIMARY CYTOREDUCTION; SURGERY; TOMOGRAPHY; CARCINOMA; CHEMOTHERAPY; VALIDATION; PREDICTORS; WOMEN; SCORE;
D O I
10.1186/s12885-017-3476-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). Methods: Patients diagnosed with EOC during 2012-2015 were analyzed retrospectively. Surgical and survival outcomes were compared between three treatment groups: patients without high tumor dissemination (HTD) who underwent primary debulking surgery (PDS group); patients with HTD who underwent DLS (DLS group); and patients with HTD diagnosed by cytological confirmation of malignancy followed by neoadjuvant chemotherapy (NACT group). Results: Of 181 patients, 85, 38, and 58 underwent PDS, DLS, and NACT, respectively. Among the 38 consecutive patients who initially underwent DLS, 6 were considered suitable for PDS; the remaining 32 were eligible for NACT followed by interval debulking surgery. The median operative times of debulking surgery in the PDS, DLS, and NACT groups were 365 min (interquartile range [ IQR]: 216.5-476.5 min), 266.2 min (IQR: 160.3-193. 5 min), and 339.0 min (IQR: 205-425 min; P = 0.042), respectively, with respective median estimated blood loss volumes of 962.2 mL (IQR: 300-1037.5 mL), 267.1 mL (IQR: 150-450 mL), and 861.7 mL (IQR: 150-1200 mL; P = 0.023). The DLS group had significantly reduced transfusion requirements and intensive care unit admission rates (P = 0.006). The Kaplan-Meier survival analysis indicated significantly poor PFS in the NACT group. However, there was no significant difference in OS among the three groups. Conclusions: The consecutive steps of imaging, frailty assessment, and DLS might facilitate rapid assessments of peritoneal disease extent and resectability; this novel algorithm might also be used to individualize treatment.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [41] TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CANCER - PAST, PRESENT AND FUTURE
    HOSKINS, PJ
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1995, 20 (1-2) : 41 - 59
  • [42] Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    Kong, Catherine Shu Shya
    INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE, 2013, 11 (02): : 144 - 144
  • [43] Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    Coleridge, Sarah L.
    Bryant, Andrew
    Lyons, Thomas J.
    Goodal, Richard J.
    Kehoe, Sean
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [44] Latest research and treatment of advanced-stage epithelial ovarian cancer
    Robert L. Coleman
    Bradley J. Monk
    Anil K. Sood
    Thomas J. Herzog
    Nature Reviews Clinical Oncology, 2013, 10 : 211 - 224
  • [45] Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer
    Ezgi Guler
    Daniel A. Smith
    Bhanusupriya Somarouthu
    Rahul Gujrathi
    Nikhil H. Ramaiya
    Sree Harsha Tirumani
    Abdominal Radiology, 2020, 45 : 828 - 841
  • [46] COMPARISON BETWEEN 'FAGOTTI' DIAGNOSTIC LAPAROSCOPY AND 'SUIDAN' CRITERIA FOR THE AVOIDANCE OF SUBOPTIMAL LAPAROTOMIES IN ADVANCED OVARIAN CANCER
    Zouzoulas, D.
    Tsolakidis, D.
    Theodoridis, T.
    Zepiridis, L.
    Lioupis, M.
    Pados, G.
    Grimbizis, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A552 - A552
  • [47] COULD IMAGING PREDICT LYMPH NODE INVASION IN ADVANCED EPITHELIAL OVARIAN CANCER?
    Adrien, C.
    Mimoun, C.
    Mezzadri, M.
    Marchand, E.
    Touboul, C.
    Place, V.
    Benifla, J. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A429 - A429
  • [48] Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer
    Guler, Ezgi
    Smith, Daniel A.
    Somarouthu, Bhanusupriya
    Gujrathi, Rahul
    Ramaiya, Nikhil H.
    Tirumani, Sree Harsha
    ABDOMINAL RADIOLOGY, 2020, 45 (03) : 828 - 841
  • [49] Re: "Diagnostic open laparoscopy in the management of advanced ovarian cancer" - Reply to Fagotti et al.
    Panici, Pierluigi Benedetti
    Palaia, Innocenza
    Plotti, Francesco
    Calcagno, Marco
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 373 - 374
  • [50] Novel Advances in Qualitative Diagnostic Imaging for Decision Making in Multidisciplinary Treatment for Advanced Esophageal Cancer
    Okazumi, Shinichi
    Ohira, Gaku
    Hayano, Koichi
    Aoyagi, Tomoyoshi
    Imanishi, Shunsuke
    Matsubara, Hisahiro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)